Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment. (Q39024988)
Jump to navigation
Jump to search
scientific article published on 11 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment. |
scientific article published on 11 February 2014 |
Statements
Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment (English)
Sonia Moretti
Elisa Menicali
Pasquale Voce
Silvia Morelli
Sara Cantarelli
Renato Colella
Alessia Alunno
Vittorio Bini
Maria Grazia Mameli
Sebastiano Filetti
Massimo Santoro
Nicola Avenia
Efisio Puxeddu
11 February 2014